NaPDI | Compound details

Notice: This website is expected to be retired soon because project funding has ended. Content and services may become unavailable after that time. For questions about archived materials or ongoing access, please contact the project team.

Need public description.

Natural products containing this compound

Enantiomer of compound
None listed

Compound has enantiomers
None listed

Metabolite of compounds
None listed

Compound has metabolites
None listed

ID	Subject of Study	Study Name	Name	Type	Overall Effect	Enzymes	Transporters	Object	Object Metabolite	Precipitant
NPDI-DqfMEw	Cannabis (Cannabis sativa)	Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol	Cannbidiol-2'-monomethyl ether	In Vitro Enzyme Inhibition	positive — In Vitro Enzyme Inhibition	CYP1A1		7-ethoxyresorufin	resorufin	cannabidiol-2'-monomethyl ether
NPDI-E6xHTA	Cannabis (Cannabis sativa)	Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.	Cannabidiol-2'-monomethyl ether	In Vitro Enzyme Inhibition	positive — In Vitro Enzyme Inhibition	CYP1A1		7-ethoxyresorufin	resorufin	cannabidiol-2'-monomethyl ether

ID	Subject of Study	Name
NPDI-Z6vbAA	Cannabis (Cannabis sativa)	Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol
NPDI-Ujn_7A	Cannabis (Cannabis sativa)	Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.